Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2007, p. 2625-2627, Vol. 51, No. 7
0066-4804/07/$08.00+0 doi:10.1128/AAC.00107-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Department of Laboratory Medicine,1 Paik Institute for Clinical Research, College of Medicine, Inje University, Busan,2 Department of Laboratory Medicine, College of Medicine, Ulsan University, Ulsan,3 Department of Laboratory Medicine, College of Medicine, Kosin University, Busan,4 Department of Laboratory Medicine, School of Medicine, Gyeongsang National University, Jinju,5 Department of Laboratory Medicine, School of Medicine,6 Medical Research Institute, Pusan National University, Busan, Korea7
Received 24 January 2007/ Returned for modification 21 March 2007/ Accepted 7 May 2007
The genes erm(B), mef(A), and both erm(B) and mef(A) were identified in 42.6, 10.1, and 47.3%, respectively, of the erythromycin-resistant Streptococcus pneumoniae isolates. Of the strains, 3.8% were nonsusceptible to levofloxacin and had 1 to 6 amino acid changes in the quinolone resistance-determining region, including a new mutation, Asn94Ser, in the product of parC. Levofloxacin with reserpine was highly specific for efflux screening.
Published ahead of print on 14 May 2007.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»